ArticleInternal and emergency medicine2008

Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing.

Rita Banzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.